source
- FTC settlement forces CVS Caremark to change insulin pricing, could save US patients $8.5 billionThe Federal Trade Commission announced it has settled a lawsuit against CVS Caremark, one of the nation's largest pharmacy benefit managers, over claims the company inflated insulin prices and rest…
- CVS Caremark settles FTC antitrust case, agreeing to favor lowest-cost insulin on formulariesCVS Caremark announced a settlement with the Federal Trade Commission that resolves the agency’s antitrust lawsuit alleging the PBM favored higher-priced insulin versions. Under the agreement, Car…